CAMP4 Therapeutics CorporationCAMPNASDAQ

Revenue (LTM)

$3M

+436.5% YoY

Net Income (LTM)

$-80M

-55.2% YoY

Free Cash Flow

$-30M

Revenue CAGR (5Y)

-67.0%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Feb 22	Feb 23	Nov 23	Dec 24	Dec 25
Revenue	296	0	0	1↑86.3%	3↑436.5%
Gross Profit	122	0	0	1↑86.3%	2↑185.1%
Operating Income	-15	-45↓193.9%	-52↓15.3%	-53↓2.3%	-52↑1.9%
Net Income	-31	-44↓41.9%	-49↓11.5%	-52↓5.1%	-80↓55.2%
EBITDA	7	-44↓689.0%	-50↓13.8%	-51↓2.4%	-50↑1.9%
EPS Diluted	-0.88	-0.90↓2.3%	-4.07↓352.2%	-2.66↑34.6%	-2.65↑0.4%

Metric	Feb 22	Feb 23	Dec 23	Dec 24	Dec 25
Cash & Equivalents	91	83↓8.7%	38↓53.9%	64↑66.9%	110↑71.0%
Total Current Assets	194	84↓56.4%	40↓52.6%	66↑65.9%	114↑71.9%
Total Assets	402	103↓74.5%	55↓46.4%	78↑42.5%	118↑50.4%
Total Current Liabilities	95	8↓91.6%	8↓1.7%	10↑22.9%	16↑61.6%
Total Liabilities	322	180↓44.1%	179↓0.8%	15↓91.5%	70↑362.3%
Total Equity	80	-78↓196.7%	-124↓59.6%	63↑151.0%	48↓24.5%
Total Debt	209	12↓94.1%	12↓5.7%	9↓26.0%	2↓77.2%
Net Debt	118	-71↓160.0%	-27↑62.3%	-55↓107.6%	-108↓94.2%

Metric	Feb 22	Feb 23	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-4	-39↓813.8%	-44↓14.6%	-46↓3.2%	-30↑35.1%
Capital Expenditure	-13	-4↑69.7%	-1↑83.2%	-0↑35.0%	-0↑36.7%
Free Cash Flow	-18	-43↓143.0%	-45↓5.3%	-46↓2.6%	-30↑35.2%
Stock-Based Comp	11	1↓87.8%	3↑111.1%	4↑38.7%	4↓0.8%
Net Change in Cash	-15	83↑640.1%	-45↓153.5%	26↑157.6%	46↑79.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance